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Jongho Kim, MD, PHD,* Erika D. Feller, MD,y Wengen Chen, MD, PHD,* Vasken Dilsizian, MD*HEART FAILURE IS A MAJOR CAUSE OF MORBIDITY AND MORTALITY, particularly among patients with
advanced disease and no access to cardiac transplantation. Owing to the constant shortage of donor hearts,
the role of left ventricular assist device (LVAD) has been expanding in the management of these patients both
as a bridge to transplantation and as a destination therapy (i.e., alternative to transplantation) (1). Although
lifesaving, LVAD is often complicated with infections. In the REMATCH (Randomized Evaluation of
Mechanical Assistance for the treatment of Congestive Heart Failure Trial), where LVAD was ﬁrst evaluated
as destination therapy, 42% and 52% of patients developed sepsis at 1 year and 2 years after implantation,
respectively (2).
The percutaneous driveline, that exits the abdomen, can get disrupted by normal every day activities such
as showering, which introduces bacteria. Once bacteria infect the driveline and then the bloodstream, eradi-
cation of infection is difﬁcult. Bacteria can infect all areas of the LVAD including driveline, pump, cannula, and
tissues surrounding the pump. Treatment modalities include long-term antibiotics, LVAD replacement,
debridement, and urgent transplant. LVAD infection portends poor prognosis, and treatment options are
limited.
We present a negative (Fig. 1) and a series of LVAD infection cases (Figs. 2 to 5) demonstrating classic imaging
manifestations on 18F-ﬂuorodeoxyglucose positron emission tomography/computed tomography (FDG PET/
CT). FDG PET/CT imaging of the LVAD is a potential tool to make an early and accurate diagnosis of LVAD
infection. FDG PET/CT imaging may allow earlier detection of LVAD infection and its extent, as well as
evaluation of response to therapy.From the *Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore,
Maryland; and the yDepartment of Medicine, Division of Cardiovascular Medicine, University of Maryland School of Medicine,
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FIGURE 1 Negative FDG PET/CT
Examination
An example of a 61-year-old male patient
with ischemic cardiomyopathy status post-
HeartMate II left ventricular assist device
(LVAD) implantation with no evidence of
LVAD infection. On the baseline study at
1 year and 2 months after implantation,
computed tomography (CT) attenuation-
corrected (AC) positron emission tomogra-
phy (PET) (ﬁrst row), localizing low-dose CT
(second row), fused AC PET/CT (third row),
and non-AC PET (fourth row) of axial
(left column), coronal (middle column),
and sagittal (right column) images show no
evidence of abnormally increased ﬂuo-
rodeoxyglucose (FDG) activity around the
LVAD in the thorax and upper abdomen
along the pump pocket (solid arrow) or
outﬂow cannula exterior (open arrow) (A).
There is no abnormal metabolic uptake
along the driveline (open arrowhead)
from the left upper abdomen downward
into the right lower abdominal exit
(solid arrowhead) in the coronal images (B).
The patient has been event-free during the
1-year follow-up period.
FIGURE 2 Percutaneous Exit LVAD Infection
An example of a 51-year-old male patient with ischemic
cardiomyopathy status post-HeartMate II LVAD implanta-
tion, which was complicated by pump thrombosis requiring
pump replacement. At 1 year after implantation, the patient
reported pain at the driveline exit site, purulent discharge,
swelling, erythema, and fevers. The driveline and blood
culture revealed methicillin-resistant staphylococcus aureus
and propionibacterium, respectively. PET/CT images show a
focal area of increased metabolic activity conﬁned to the
percutaneous exit of the drive line (solid arrowhead) in the
right lower abdominal wall, compatible with percutaneous
exit LVAD infection. The patient underwent immediate
debridement of the driveline and subsequent urgent
heart transplantation due to failed response to antibiotic
treatment. Abbreviations as in Figure 1.
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FIGURE 3 Driveline LVAD Infection
An example of a 45-year-old male patient with familial
nonischemic dilated cardiomyopathy status post-HeartWare
LVAD implantation. At 6 months after implantation, the
patient reported pain, purulent discharge, and nonhealing
at the driveline exit site. The driveline culture revealed
coagulase-negative staphylococcus aureus and yeast. PET/CT
images show intense linear FDG uptake along the driveline
(open arrowhead) and percutaneous exit (solid arrowhead)
that is compatible with driveline LVAD infection. The patient
underwent revision of the driveline and subsequent urgent
heart transplantation due to failed response to antibiotic
treatment. Abbreviations as in Figure 1.
FIGURE 4 Cannula Exterior LVAD Infection
An example of a 68-year-old male patient with ischemic
cardiomyopathy status post-HeartMate II LVAD implantation.
At 1.5 years after implantation, the patient developed leuko-
cytosis and hypotension requiring intravenous pressors. Both
wound and catheter tip cultures revealed pseudomonas with
klebsiella and pseudomonas from the sputum. PET/CT images
show intense linear metabolic activity along the outﬂow
cannula exterior (open arrow) attached to the ascending
aorta, more prominent in the distal portion than the proximal
metallic portion near the pump, which is consistent with
cannula exterior LVAD infection. The patient died of septic
shock and multiorgan failure despite device explantation and
comprehensive antibacterial and antifungal antibiotic
coverage. Abbreviations as in Figure 1.
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FIGURE 5 Pump Pocket LVAD Infection
An example of a 58-year-old male patient
with nonischemic cardiomyopathy status
post-HeartMate II LVAD implantation. At
3.5 years after implantation, the patient
developed hypotension following chronic
purulent discharge from the driveline exit
site under coverage of antibiotic therapy.
Both driveline and blood culture revealed
pseudomonas in addition to proteus from
the driveline. PET/CT images show
increased FDG uptake corresponding to the
LVAD pump pocket (solid arrow) and can-
nula exterior (open arrow) connecting to
ascending aorta, which is conﬁrmed on non-
AC PET (fourth row) as a focal uptake at the
pump pocket (curved arrow), compatible
with pump pocket LVAD infection.
In addition, there is abnormal FDG uptake
within the subcutaneous soft tissues along
the course of the LVAD driveline
(open arrowhead) in the mid-abdomen. The
patient died of septic shock despite
debridement of the driveline along with
aggressive antibiotic treatment.
Abbreviations as in Figure 1.
Kim et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 8 , 2 0 1 4
FDG PET-CT Imaging for LVAD Associated Infections A U G U S T 2 0 1 4 : 8 3 9 – 4 2
842REPRINT REQUESTS AND CORRESPONDENCE: Dr. Vasken Dilsizian, University of Maryland School of
Medicine and Medical Center, Department of Diagnostic Radiology and Nuclear Medicine, 22 South Greene
Street, Room N2W78, Baltimore, Maryland 21201. E-mail: vdilsizian@umm.edu.
RE F E RENCE S1. Kirklin JK, Naftel DC, Kormos RL, et al. Second
INTERMACS annual report: more than 1,000 pri-
mary left ventricular assist device implants.
J Heart Lung Transplant 2010;29:1–10.2. Holman WL, Park SJ, Long JW, et al., for
the REMATCH Investigators. Infection in perma-
nent circulatory support: experience from the
REMATCH trial. J Heart Lung Transplant 2004;23:
1359–65.KEY WORDS cardiac device infection,
ﬂuorodeoxyglucose, heart failure, left
ventricular assist device, PET/CT
